skip to main content
Idioma:
Refinado por: assunto: Aged remover autor: Wheatley, Duncan remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Lin, Nancy U. ; Winer, Eric P. ; Wheatley, Duncan ; Carey, Lisa A. ; Houston, Stephen ; Mendelson, David ; Munster, Pamela ; Frakes, Laurie ; Kelly, Steve ; Garcia, Agustin A. ; Cleator, Susan ; Uttenreuther-Fischer, Martina ; Jones, Hilary ; Wind, Sven ; Vinisko, Richard ; Hickish, Tamas

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.1057-1065 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.